New Enterprise Associates 15, L.P.
CIK 1629794 · last filed 2025-10-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AVEO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
TIMONIUM, MD 21093
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NeueHealth, Inc. (BHG) Delisted | Director | 1,527,217 | $16.35 | $24.97M | -$3.8K | 2 | 2025-10-06 |
| NeueHealth, Inc. (NEUE) Delisted | 10%+ Owner | — | $6.75 | — | $0 | 1 | 2024-04-10 |
| Arcellx, Inc. (ACLX) Delisted | 10%+ Owner | 4,745,262 | $115.07 | $546.04M | $0 | 1 | 2022-12-22 |
| IONQ.WS | 10%+ Owner | 14,614,829 | $33.55 | $490.33M | $0 | 1 | 2022-11-18 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 0 | $15.00 | $0 | $3.95M | 5 | 2022-10-21 |
| HOOD | Director | 71,468,726 | $101.93 | $7.28B | $0 | 1 | 2021-11-12 |
| Desktop Metal, Inc. (DM) Delisted | 10%+ Owner | 1,926,341 | $4.96 | $9.55M | $0 | 1 | 2021-06-10 |
| Eargo, Inc. (EAR) Delisted | 10%+ Owner | 226,001 | $2.57 | $580.8K | $0 | 1 | 2021-05-26 |
Recent Filings · Page 2 of 2
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-12-10 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +681,600 | $1.35M | EDGAR |
| 2018-11-30 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +385,600 | $763.6K | EDGAR |
| 2018-11-21 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Buy (P) | +680,000 | $1.34M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.